Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject

Mya Schiess

Status

Conditions: Parkinson Disease

Treatments: Biological: Allogeneic bone marrow-derived mesenchymal stem cells

Study type: Expanded Access

Funder types: Other

Identifiers

NCT06798064

HSC-MS-24-1279

Details and patient eligibility

About

This is a expanded access use of allogeneic bone marrow-derived mesenchymal stem cells for a single subject with moderate Parkinson's disease that has progressed.

Sex: All

Ages: 50 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria